I think the best thing to say is that by thinking through the example, sharing it with people in the field, and then steelmanning it, he might have had some good points: 1) pharma would love to understand the mechanisms of drugs in detail but we don't have that. AI could help. 2) there is a possibility that a clinical trial run by AI could hack the trial get something approved when it wasn't safe or effective.